ArticleCancer research and treatment2015

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines.

Sung-Ung Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.